Print

RXi Pharmaceuticals (RXII) Announces Investor and Analyst Symposium  
4/29/2013 6:34:11 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it will hold its first Investor and Analyst Symposium.

Help employers find you! Check out all the jobs and post your resume.

//-->